Indications 

Kerydin Topical Solution is indicated for the treatment of onychomycosis, a fungal toenail infection resulting in nail discoloration, splitting, or pain. 

As an oxaborole antifungal, Kerydin Topical Solution functions by halting the growth of nail fungus. 

Uses and Dosage 

Read the accompanying medication guide and patient information leaflet of Kerydin Topical Solution before initial use and with each prescription refill. Consult your doctor if you have queries or need additional information. 

Typically, Kerydin Topical Solution is applied once a day to the affected toenails as prescribed by the doctor for a duration of 48 weeks. 

To properly apply this solution: 

1. Ensure your toenails are clean and dry. 
2. For first-time use, remove the cap from the topical solution bottle and dispose of it. Unwrap the dropper and insert it into the bottle. 
3. Squeeze the dropper bulb, then release it to fill the dropper with medication. 
4. Hold the dropper over the affected toenail and slowly squeeze the bulb to apply enough medication to cover the entire toenail.  
   • You may need more than one drop. 
5. Use the dropper tip to spread the medication across the entire toenail. 
6. Position the dropper under the toenail tip, squeezing the bulb to apply medication to the skin beneath the toenail.  
   • Use the dropper tip to spread the medicine under the toenail. 
7. If medication gets on the skin around the toenail, use a tissue to wipe it off.  
   • Do not wipe the medication off the toenail itself. 
8. For multiple affected toenails, repeat steps 3-7 to apply medication to each toenail. 
9. After application, place the dropper back into the medication bottle and securely screw it on. 
10. Let your toenails dry for a few minutes. 
11. Wash your hands thoroughly with soap and water after applying the solution. 

Use Kerydin Topical Solution regularly, exactly as directed, to get the most benefit from it. Establish a daily routine by using it at the same time each day to aid in adherence. 

Adhere to the full duration of the prescribed treatment with this topical solution, even if symptoms subside within a few days. Extended treatment is often necessary to grow healthy nails to replace infected ones. Ceasing the medication prematurely could lead to a recurrence of the infection. 

Side Effects 

Common Side Effects: 

• Peeling or redness at the application site 
• Itching 
• Ingrown toenail 

Promptly notify your doctor if any of the above-listed common side effects persist or worsen. 

Serious Side Effects 

• Severe redness, swelling, or irritation of the affected toenail 

Contact your doctor right away if you experience serious side effects. 

Allergic Reactions 

Although rare, a severe allergic reaction to Kerydin Topical Solution can occur. Seek prompt medical attention if you notice symptoms such as: 

• Hives 
• Breathing difficulties 
• Swelling of the face, lips, tongue, or throat 

This list does not include all potential side effects of Kerydin Topical Solution. Inform your doctor should you observe any unlisted effects. 

Cautions 

Before starting treatment with Kerydin Topical Solution, inform your doctor if you have any known allergies, particularly to tavaborole or any of the ingredients in this topical solution. 

Inform your doctor about your medical history before using Kerydin Topical Solution to evaluate its safety for your condition. 

Other medications may have an impact on each other, but Kerydin Topical Solution is not typically affected by them. To ensure safe usage, inform all healthcare providers about your complete medication regimen, including prescriptions, over-the-counter drugs, vitamins, and herbal products. 

Kerydin Topical Solution is flammable. Avoid exposure to heat and flames during application, and refrain from smoking until the solution has fully dried on your nail. 

The potential effects of Kerydin Topical Solution on an unborn baby are not established. Notify your doctor if you are pregnant or intend to conceive while using this medication. 

The transmission of tavaborole through breast milk and its potential impact on a nursing infant is not determined. Consult your doctor regarding any associated risks.